India's Solara Active Pharma rises on upbeat forecast
** Shares of Solara Active Pharma Sciences SOLA.NS up 4.8%
at 486.25 rupees
** API maker targets to double its operating profit by the
end of fiscal 2025 from Q4 FY24, per transcript of post-earnings
investor call made public post-market hours on Tuesday
** SOLA reported a Q3 loss vs profit on Feb. 14
** Trading volume 4.3x the 30-day moving average
** Stock up ~35% YTD after falling for three straight years
(Reporting by Kashish Tandon in Bengaluru)
((kashish.tandon@thomsonreuters.com))
Recent news on Solara Active Pharma Sciences
See all newsIndia's Solara Active Pharma Sciences rises after quarterly profit
Brief: Solara Active Pharma Sciences Says Sept-Quarter Consol Net Profit 284.6 Million Rupees
Brief: Solara Active Pharma Sciences Says Tax Demand Of 1.62 Billion Rupees Reduced To Nil After Rectification
Brief: Solara Active Pharma Sciences June-Quarter Consol Net Profit 163.1 Million Rupees
Brief: Solara Active Pharma Sciences March-Quarter Consol Net Profit 96 Million Rupees